Expected Moves

Expected timeline for capital restructuring or equity dilution required to address the company's deeply negative free cash flow (-$14.6M TTM) and -1.45x interest coverage.

Sector-wide macro event evaluating potential shifting federal cannabis stances under President Trump's administration and subsequent cross-border trade implications.

Third-quarter earnings, detailing margin compression and potential impacts of any recent liquidity injections or restructuring efforts.

Full-year 2026 results release, serving as a critical viability checkpoint for ongoing operations.